www.curehiv.us
Cure HIV - Prevention And Treatment Of HIV / AIDS

Cure HIV, Inc. Who We Are Events & Newsletters Contact Us
 

  Cure HIV, Inc. 2010

Clinical Overview of HIV Disease

Section 4: Transmission and Risk Factors

The primary method of spread of HIV infection worldwide is through sexual exposure. In the United States and Europe, acquisition of the virus through homosexual contact remains important, and there is some evidence of increasing incidence of infection among young gay men and ethnic minorities.( 76 ) MSM, however, now account for <50% of new infections in the United States.( 76 ) In the areas of highest HIV prevalence globally, heterosexual intercourse is the primary mode of transmission, accounting for approximately 70% of the overall sexual transmission.( 77 )

HIV has been isolated from blood, seminal fluid, pre-ejaculate, vaginal secretions, cerebrospinal fluid, saliva, tears, and breast milk of infected individuals.( 78-81 ) HIV-1 DNA sequences have also been detected in pre-ejaculatory fluid.( 82 ) In genital fluids, HIV may be found in both cell-free and cell-associated compartments, but it is unknown which is responsible for productive infection.( 83 ) Viral concentrations in tears and saliva are comparatively low, and there are substances in saliva that appear to inhibit infectivity. No cases of HIV infection have been documented to arise from contact with nonbloody saliva or tears.

Transmission of HIV occurs more frequently through penile-anal intercourse and penile-vaginal intercourse than through fellatio, although clear cases of transmission through oral sex exist.( 310 ) Female-to-female HIV transmission has been reported, but is rare.( 88 ) In a meta-analysis, the overall efficacy of condoms in reducing HIV transmission was 69%.( 89 )

Sexual activity that is associated with exposure to infected blood increases the risk of transmission, as does the presence of genital ulcers.( 90-92 ) Serum HIV viral load is strongly associated with heterosexual transmission between HIV-serodiscordant African sexual partners, where transmission was noted to be rare at viral loads <1,500 copies/mL.( 93 ) The effect of viral load reduction with ART on HIV transmission is being investigated. Intervention with antiretroviral medications soon after high-risk sexual exposures has been proven to be safe and may be effective in preventing transmission of HIV (as discussed in the chapter " Prophylaxis Following Nonoccupational Exposure to HIV ").( 104 )

Nonsexual HIV transmission can occur through transfusion with contaminated blood products, injection drug use, occupational exposure, or accidental needlesticks. The risk from occupational needlesticks to health care workers from known HIV-positive source patients in case series performed prior to the availability of potent ART was found to be 0.33-0.5%.( 95,96 ) Factors increasing the risk of HIV acquisition from an occupational needlestick include deep injury, injury with a visibly bloody device, or injury with a device that had been previously used in the source patient's vein or artery.( 96 ) Postexposure prophylaxis (PEP) has been associated with a reduction of HIV transmission after occupational needlestick events of approximately 80%.( 96,103 )

HIV transmission through transfusion of contaminated blood products was recognized early in the epidemic.( 6 ) With current testing methods, the risk of acquiring HIV from a unit of transfused blood in the United States is 1 in 676,000,( 102 ) but is significantly higher in many developing countries.

In the absence of interventions, mother-to-child transmission occurs in approximately 25% of live births to HIV-infected mothers.( 97 ) Various regimens of antiretrovirals can reduce the rate of perinatal transmission by 50% or more.( 97-100,311 ). Breast-feeding is also a risk factor for HIV transmission. Approximately one-third of cases of mother-to-child transmission result from breast-feeding, and the risk increases with the duration of breast-feeding.( 101 ) Thus, interventions to prevent mother-to-child transmission at delivery may be largely negated if mothers are not provided with safe alternatives to breast-feeding.
 

« Previous Table of Contents Next »

 

Liability: Cure HIV, Inc. does not warrant or assume any legal liability or responsibility for the accuracy or completeness of any information disclosed on www.curehiv.us website.

Medical information: Cure HIV, Inc. does not intend to provide specific medical advice or treatment. Cure HIV, Inc. intends to provide the website visitors with documents and information to better understand HIV / AIDS and its prevention and treatment.
  Design and Development 300Pix Donate Now | Cure HIV, Inc. | Who We Are | Roger K. Hershline, Ph.D. MD | Contact Us
Learn About HIV / AIDS | What Is This Medication | Why Is This Medication So Important
Events And Newsletters | The Patent | Global Humanceuticals, Inc. | Glossary